Reduction of prices of medicines leads to savings of at least 250 million Swiss francs from 2020 to 2022
4 November 2022 – The Federal Office of Public Health (FOPH) has reduced the prices of a good 300 medicines by an average of 10% as part of its triennial review for 2022. Savings of at least 60 million Swiss francs are expected as a result of this review. Thanks to the 2020 to 2022 review period, the FOPH thus expects savings of at least 250 million Swiss francs.
For more information, see here.